Chimeric antigen receptor T-cell therapy: challenges and opportunities in lung cancer
{{output}}
Chimeric antigen receptor (CAR) T-cell therapy has revolutionized the paradigm in hematological malignancies treatment, driving an ever-expanding number of basic research and clinical trials of genetically engineering T cells to treat solid tumors. CAR T-cell ... ...
